Newsroom

A New Delivery System Offers Hope for Cystic Fibrosis

While the CRISPR-Cas9 genome editor has the potential to revolutionize the treatment of genetic diseases, targeted delivery strategies, such as to the lungs, have been lacking. CRISPR-carrying lipid nanoparticles enabled researchers to correct a rare nonsense mutation...

Read Article

Chromatin accessibility: A new avenue for gene editing

TFDP1, a modulator of genome accessibility. In a study recently published in Nature Genetics, researchers from Nano Life Science Institute (WPI-NanoLSI), Kanazawa University explore chromatin accessibility, i.e., endogenous access pathways to the genomic DNA, and its...

Read Article